Activity of rat UGT1A1 towards benzo[a]pyrene phenols and dihydrodiols

被引:3
作者
Webb, L [1 ]
Miles, K [1 ]
Kessler, F [1 ]
Ritter, JK [1 ]
机构
[1] Virginia Commonwealth Univ, Sch Med, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA
关键词
UDP-glucuronosyltransferase; benzo[a]pyrene; glucuronidation; environmental carcinogenesis;
D O I
10.1016/j.etap.2005.07.018
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Four UDP-glucuronosyltransferases from the rat UGT1A family were tested for activity towards benzo[a]pyrene pyenols and dihydrodiols. UGTIA1 and UGTI1A7 were found to be broadly active towards BaP metabolites. Antisera recognizing rat UGT1A1 and UGT1A7 were used to assess UGT levels in relation to UGT activity towards benzo[a]pyrene-7.8-dihydrodiol (BPD). The rank BPD UGT activities were liver=intestine kidney, whereas UGT1A1 was highest in liver and UGT1A7 was highest in intestine. Phenobarbital, an inducer of hepatic UGT1A1, only slightly increased BPD UGT activity, whereas UGT1A7 inducers more potently increased the activity. Inhibition studies using the differential UGTIAI inhibitor, bilirubin, suggest that UGT1A1 is not a major contributor to the constitutive BPD glucuronidating activity of control rat liver microsomes. These data suggest that multiple UGT1A enzymes contribute to glucuronidation of BPD and other BaP metabolites, and that their relative contributions depend on tissue- and environmental-specific factors. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:224 / 230
页数:7
相关论文
共 50 条
  • [31] UGT1A1 polymorphism and hyperbilirubinemia in a patient who received sorafenib
    Meza-Junco, Judith
    Chu, Quincy S. -C.
    Christensen, Olaf
    Rajagopalan, Prabhu
    Das, Soma
    Stefanyschyn, Ruslan
    Sawyer, Michael B.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 65 (01) : 1 - 4
  • [32] Raloxifene glucuronidation in liver and intestinal microsomes of humans and monkeys: contribution of UGT1A1, UGT1A8 and UGT1A9
    Kishi, Naoki
    Takasuka, Akane
    Kokawa, Yuki
    Isobe, Takashi
    Taguchi, Maho
    Shigeyama, Masato
    Murata, Mikio
    Suno, Manabu
    Hanioka, Nobumitsu
    XENOBIOTICA, 2016, 46 (04) : 289 - 295
  • [33] The Association Between Heterozygosity for UGT1A1*6, UGT1A1*28, and Variation in the Serum Total-Bilirubin Level in Healthy Young Japanese Adults
    Moriya, Hiroyuki
    Saito, Katsuhiko
    Helsby, Nuala
    Sugino, Shigekazu
    Yamakage, Michiaki
    Takasaki, Masahiko
    Kato, Hidenori
    Kurosawa, Nahoko
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2013, 17 (06) : 464 - 469
  • [34] Pharmacophore and quantitative structure activity relationship modelling of UDP-glucuronosyltransferase 1A1 (UGT1A1) substrates
    Sorich, MJ
    Smith, PA
    McKinnon, RA
    Miners, JO
    PHARMACOGENETICS, 2002, 12 (08): : 635 - 645
  • [35] Enhanced UGT1A1 Gene and Protein Expression in Endometriotic Lesions
    Carla A. Piccinato
    Rosa M. Neme
    Natália Torres
    Elivane da Silva Victor
    Heloísa F. Brudniewski
    Júlio C. Rosa e Silva
    Rui A. Ferriani
    Reproductive Sciences, 2018, 25 : 1371 - 1375
  • [36] Effects of UGT1A1*28 polymorphism on raloxifene pharmacokinetics and pharmacodynamics
    Trontelj, Jurij
    Marc, Janja
    Zavratnik, Andrej
    Bogataj, Marija
    Mrhar, Ales
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 67 (04) : 437 - 444
  • [37] UGT1A1*28 polymorphism as a determinant of irinotecan disposition and toxicity
    Iyer L.
    Das S.
    Janisch L.
    Wen M.
    Ramírez J.
    Karrison T.
    Fleming G.F.
    Vokes E.E.
    Schilsky R.L.
    Ratain M.J.
    The Pharmacogenomics Journal, 2002, 2 (1) : 43 - 47
  • [38] Enhanced UGT1A1 Gene and Protein Expression in Endometriotic Lesions
    Piccinato, Carla A.
    Neme, Rosa M.
    Torres, Natalia
    Victor, Elivane da Silva
    Brudniewski, Heloisa F.
    Rosa e Silva, Julio C.
    Ferriani, Rui A.
    REPRODUCTIVE SCIENCES, 2018, 25 (09) : 1371 - 1375
  • [39] UGT1A1 Mediated Drug Interactions and its Clinical Relevance
    Goon, Chong Ping
    Wang, Ling Zhi
    Wong, Fang Cheng
    Thuya, Win Lwin
    Ho, Paul Chi-Lui
    Goh, Boon Cher
    CURRENT DRUG METABOLISM, 2016, 17 (02) : 100 - 106
  • [40] Recent progress and challenges in screening and characterization of UGT1A1 inhibitors
    Lv, Xia
    Xia, Yangliu
    Finel, Moshe
    Wu, Jingjing
    Ge, Guangbo
    Yang, Ling
    ACTA PHARMACEUTICA SINICA B, 2019, 9 (02) : 258 - 278